Views & Analysis How the NHS got ahead of the curve with CAR-T The UK’s pharma industry has welcomed the NHS’ fast adoption of the latest CAR-T cancer therapies.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
